Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03362697Completed
Randomised, double-blind trial in urinary tract infection (UTI), asymptomatic bacteriuria (ASB) and cystitis, sponsored by Innovación y Desarrollo de Estrategias en Salud. Primary endpoint: Clinical and/or Bacteriological cure at 14 days. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03362697.